Dark Forest Capital Management’s Immunovant IMVT Stock Holding History

Dark Forest Capital Management’s Portfolio IMVT Stock Details IMVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$256K	Sell	6,650 -7,546	-53%	-$230K	0.02%	753
2026 Q1	$353K	Buy	14,196 +132	+0.9%	+$3.42K	0.03%	641
2025 Q4	$358K	Buy	+14,064	New	+$314K	0.02%	863
2025 Q2	–	Sell	-31,726	Closed	-$542K	–	1342
2025 Q1	$542K	Buy	+31,726	New	+$664K	0.02%	896
2023 Q4	–	Sell	-10,282	Closed	-$395K	–	775
2023 Q3	$395K	Buy	+10,282	New	+$232K	0.03%	802
2021 Q4	–	Sell	-578	Closed	-$5K	–	1590
2021 Q3	$5K	Buy	+578	New	+$5.21K	﹤0.01%	1089

Other funds holding IMVT

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dark Forest Capital Management's IMVT Position: Q2 2026 in Review

Dark Forest Capital Management reduced its Immunovant (IMVT) stake by 53% in Q2 2026, selling an estimated $230K and leaving 6,650 shares worth $256K. The position accounts for 0.02% of the portfolio, ranked #753.

Dark Forest Capital Management first reported a position in IMVT in Q3 2021 and has held it in 6 quarters since. The position peaked at $542K in Q1 2025. 226 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

Dark Forest Capital Management held 6,650 shares of Immunovant worth $256K as of Q2 2026.
Dark Forest Capital Management sold 7,546 Immunovant shares in Q2 2026, an estimated $230K.
Immunovant made up 0.02% of Dark Forest Capital Management's portfolio in Q2 2026, its #753 holding.
Dark Forest Capital Management first reported a position in Immunovant in Q3 2021 and has held it in 6 quarters since.
Dark Forest Capital Management's Immunovant position peaked at $542K in Q1 2025.
226 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on Dark Forest Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.